About Simon Jenkins, PhD


Simon Jenkins, PhD joined Sermonix Pharmaceuticals as Vice President of Operations in 2018. Simon has over 30 years of experience in global drug development leadership roles across a range of therapeutic areas including asthma, inhalation device development, cardiovascular, menopausal health, osteoporosis and oncology. He has a track record of regulatory approvals in the United States, Europe and Japan.

In particular, at Wyeth/Pfizer he led the global regulatory development programs for bazedoxifene and CE/bazedoxifene (Duavee), working closely with Barry Komm.

Simon has extensive experience of the leading cross functional development teams through all aspects of drug development to which he brought strong team and entrepreneurial skills to ensure team collaboration, effectiveness and success.

Simon graduated with a BSc from Leeds University in the UK (Agricultural Zoology) and has a PhD from the University of Glasgow (parasite immunology).

Simon is the co-author of several scientific publications and co-inventor on a number of patents.